Inogen Inc（INGN）のニュースとイベントINGNInogen Inc

S&P 500 Falls for Third Straight Day

S&P 500 fell for the third straight day as investor enthusiasm over the possibility of a less aggressive Federal Reserve following today's benign PCE inflation data was reversed into the close.  While the Fed's preferred measure of inflation dented expectations of another rate hike in October, the impact down the Treasury yield curve was non-existent as the 10-year and the 30-year rates saw fresh multi-year highs at 5.30% and 5.65% respectively.  Tech was the only sector to end Wednesday in the green as mega-cap names buffered sentiment, while Consumer Staples, Real Estate, and Healthcare underperformed.Index futures are slightly higher in the opening hour of the evening session, with S&P e-minis and Nasdaq 100 contracts both up 0.2%.  Traders are watching the neutral market reaction to Q4 earnings out of Micron- the company exceeded estimates on both earnings and revenue and guided Q1 well above consensus on both the top and the bottom line.  However, the management also warned that its capex plans for FY27 are higher than the company's prior projections.  In Q4, Micron's capex of $10.77B was up from $7.1B in Q3 and up 119% y/y.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Bassett Furniture Industriesup 8.5%ALSO HIGHER -Monte Rosa Therapeuticsup 15.3% after announcing presentation of MRT-8102 GFORCE-1 Phase 1 StudyVicorup 8.9% after Q3 pre-announcementInogenup 6.7% after announcing plans to divest U.S. oxygen rental business and increase buybackNu Holdings Ltd.up 5.6% after denying reports of Monzo transactionRogersup 2.6% after medium-term outlookDOWN AFTER EARNINGS -Progress Softwaredown 1.8%Micron Technologydown 0.2%

Inogen Sells U.S. Oxygen Rental Business to Rotech for Up to $25M

Inogen announced that it has signed a definitive agreement to divest its U.S. oxygen rental business to Rotech Healthcare, a national provider of home respiratory and medical equipment. Under the agreement, Rotech will acquire specified rental assets for a total estimated cash consideration of up to $25M. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions. Separately, Inogen also signed a new, long-term supply agreement with Rotech, which is expected to support accelerating patient demand and access to Inogen's oxygen concentrators through Rotech's national distribution network. "These transactions strengthen our business and financial profile, sharpen our strategic focus, and enable us to continue investing in innovative solutions that improve patient outcomes," said Kevin Smith, President and Chief Executive Officer of Inogen. "Rotech's strong reputation and respiratory care expertise makes it a proven and trusted partner for our patients. Together, we are focused on providing a smooth transition for patients and ensuring continued access to high-quality oxygen therapy solutions." Inogen expects the transactions to increase both the revenue growth rate and adjusted operating income. The Rental Business generated revenue of $24.3M in the first half of 2026, representing a year-over-year decline of 9.8%. Beginning with its financial results for the third quarter of 2026, Inogen expects to present the Rental Business as discontinued operations, subject to completion of the Company's final accounting analysis. In connection with its third-quarter earnings report, the Company expects to provide additional information regarding the historical financial results of the Rental Business and the impact of the transactions on Inogen's outlook for continuing operations.

Inogen Increases Share Repurchase Authorization by $15M to $45M

Subject to the closing of the Rotech transaction, Inogen's Board of Directors has approved an increase of $15M to the company's existing share repurchase authorization, bringing the total authorization to $45M and further enhancing Inogen's ability to return capital to shareholders. The expanded authorization will expire on June 30, 2028, or when the maximum authorized dollar amount has been utilized, whichever occurs first. The Company is under no obligation to purchase a specific number of shares, and the program may be suspended or terminated at any time.